Status:

COMPLETED

Acute Influence of Resveratrol Supplementation and Beet Extract in Recovery After Exercise in Coronary Paths

Lead Sponsor:

Universidade Estadual Paulista Júlio de Mesquita Filho

Conditions:

Coronary Artery Disease

Autonomic Nervous System Disease

Eligibility:

MALE

40-79 years

Phase:

NA

Brief Summary

Introduction: Most cardiovascular diseases (CVD) can be prevented and controlled by adopting lifestyle changes, such as regular physical exercise and nutrition. Resveratrol and beverage extract promot...

Eligibility Criteria

Inclusion

  • adult men over 45 years of age
  • diagnosed with ischemic coronary artery disease and with preserved left ventricular function (above 50%), confirmed by a previous echocardiogram

Exclusion

  • Volunteers who present at least one of the following characteristics will be excluded:
  • smokers
  • alcohol drinkers
  • those who did not attend a cardiovascular rehabilitation program for at least 3 months prior to data collection
  • individuals who have known infections, metabolic and respiratory diseases that could interfere in cardiac autonomic control, unstable angina, uncontrolled hypertension, significant valvular disease, uncontrolled metabolic disease (e.g., uncontrolled diabetes and thyroid disease)

Key Trial Info

Start Date :

March 10 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2023

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT06095635

Start Date

March 10 2022

End Date

September 30 2023

Last Update

October 23 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidade Estadual Paulista

Presidente Prudente, São Paulo, Brazil, 19060-900